Clinical and Electrophysiological Patterns of Chronic Dysimmune Polyneuropathy
NCT05219383 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2022-02-02
Summary
Chronic dysimmune neuropathies (CDN) are a heterogenous group of acquired inflammatory demyelinating neuropathies including chronic inflammatory demyelinating polyneuropathies (CIDP), Lewis-Sumner Syndrome (LSS), multifocal motor neuropathy (MMN) and other rare entities.
Despite their relatively low prevalence, CDN lead to substantial costs for patients and society. CDN are usually misdiagnosed due to progressive nature of the disease with little known data regarding disease activity and treatment response
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-31
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
More Related Trials
-
Transcriptome Analysis of the Peripheral Blood in CIDP
NCT02404298 ·Status: UNKNOWN ·Phase: NA
-
A Registered Cohort Study of Immune-Mediated Neuropathies
NCT04292834 ·Status: UNKNOWN
-
InertiaLocoGraphy as a Biomarker of Immunoglobulin Therapy Efficacy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT04529291 ·Status: WITHDRAWN ·Phase: NA
-
Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
NCT01625182 ·Status: COMPLETED ·Phase: PHASE3
-
A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy
NCT05877040 ·Status: UNKNOWN ·Phase: PHASE2
-
Predictive Factors of Long Term Outcome in MMN
NCT04015934 ·Status: COMPLETED
-
Immunoglobulin Dosage and Administration Form in CIDP and MMN
NCT02111590 ·Status: COMPLETED
-
Study of Electrical Prognostic Factors of Response to Intravenous Immunoglobulin Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT03967899 ·Status: COMPLETED
-
Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT07154524 ·Status: RECRUITING
-
Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
NCT06169150 ·Status: RECRUITING
-
Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing
NCT04356781 ·Status: COMPLETED
-
IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
NCT02414490 ·Status: COMPLETED
-
Biomarkers in Polyradiculoneuropathies
NCT04249752 ·Status: UNKNOWN
-
EVALUATION OF SERUM INFLAMMATORY CYTOKINE CONCENTRATION IN HEREDITARY SENSITIVOMOTOR NEUROPATHIES
NCT06808581 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT06798012 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT05327114 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy
NCT07121985 ·Status: NOT_YET_RECRUITING
-
A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT03861481 ·Status: COMPLETED ·Phase: PHASE2
-
Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy
NCT00278629 ·Status: COMPLETED ·Phase: PHASE2
-
Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
NCT00268788 ·Status: COMPLETED ·Phase: PHASE2
-
RWE-based Treatment Patterns and Outcomes in CIDP
NCT05940922 ·Status: UNKNOWN
-
Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices
NCT07273903 ·Status: RECRUITING
-
A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT04051944 ·Status: COMPLETED ·Phase: PHASE2
-
Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT01017159 ·Status: COMPLETED ·Phase: PHASE2